STAMATELATOS
ION


Research Director, Physicist

Dr. Ion Stamatelatos is Director of Research and Head of the Nuclear Research Reactor Laboratory, at the Institute of Nuclear and Radiological Sciences, Technology, Energy & Safety, NCSR “Demokritos”. He also serves as national representative at the EURATOM Article 37 Committee, member of the Editorial Board of Applied Radiation and Isotopes and elected President of the Hellenic Nuclear Physics Society. His current research activities focus on fusion technology within the framework of the European Consortium for the Development of Fusion Energy (EUROfusion).

Dr. Stamatelatos scientific interests include development of nuclear and radiation techniques with applications in nuclear technology, biomedicine and cultural heritage studies, nuclear analytical techniques, radiation transport simulations, radiation detection and measurement, radiation protection and nuclear safety.  He has obtained research grants under H2020 EUROfusion, EFDA, IAEA and GSRT. He has authored 70 publications in peer reviewed scientific journals, about 90 publications in Conference Proceedings, as well as a number of technical reports. He has supervised 6 PhD and 16 MSc students now continuing their scientific career excelling in the areas of nuclear technology and radiation physics. He taught interaction of radiation with matter and radiation protection in nuclear installations in post-graduate courses in Greece and abroad. He has collaborated with Universities and Research Centers, such as CCFE, ENEA, IPPLM, BNL, TUDelft, UoI, resulting in common publications and research grants.

Dr. Stamatelatos holds PhD in Physics, from the University of Birmingham, UK (1991), MSc in Medical Physics from the University of Aberdeen, UK (1984) and BSc in Physics from the University of Patras, Greece (1983).

Selected Publications

Selected Grants

Approval of Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

2018-2022 | European Commission / Horizon 2020

FRINGE is a research and innovation action funded under H2020-FETOPEN program that is focused on the development of a genuinely new hybrid-technology for cancer therapy. FRINGE aim is to combine the advantages of both photo-medical and neutron-based therapies to achieve high tumor treatment efficien...

readmore-arrow

European Fusion Project

2014-2021 | European Commission / Horizon 2020

The EUROfusion programme is based on the Roadmap to the realization of Fusion Energy. The programme has two aims:

  • Preparing for ITER experiments
  • Developing concepts for the future fusion power demonstration plant DEMO
The 30 European consortium members receive r...

readmore-arrow

Fusion Emerging Technology & Fusion Technology

2008-2013 | European Commission / FP7

Scientific Coordination of the tasks:

  • Radiation damage in Fe and Fe-Cr alloys by electrical resistivity measurements
  • Short-range ordering kinetics in Fe-Cr alloys under irradiation
  • Effect of iron ion irradiation on the structural and magnetic properties of thin F...

readmore-arrow
INRASTES - Official Web Site
Skip to content